Founding CEO Barbara Fox of Avaxia Biologics Raises $2.2M

Founding CEO Barbara Fox of Avaxia Biologics Raises $2.2M

By Lori Valigra (Correspondent, Mass High Tech) Avaxia Biologics Inc., a Lexington-based developer of oral antibody drugs for the gastrointestinal tract, completed its first close of $2.2 million of a Series A financing led by angel investors, its CEO and founder...